BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 30, 2011
View Archived Issues
Vaxent and PREVENT to collaborate on group A Streptococcus vaccine
Read More
Novel agents show promise against raltegravir-resistant HIV
Read More
Synageva BioPharma expands ongoing study in LAL deficiency
Read More
Enrollment complete in phase II bavituximab trial in hepatitis C
Read More
First patient receives SanBio's novel cell therapy for disability due to stroke
Read More
NeuroSearch designs confirmatory phase III Huntexil trial and complementary studies
Read More
Aegerion gives update on European filing for lomitapide
Read More
Eisai's broad-spectrum antifungal agents display preclinical promise
Read More
YM BioSciences starts phase II trial of CYT-387 in myelofibrosis
Read More
HTI-501 enters phase I/II trial in women with cellulite
Read More
Ibalizumab shows promise in phase IIb study
Read More
Phase II trial investigates safety/efficacy of AZD-3199 in COPD
Read More
CSIR researchers disclose new antimycobacterial agents
Read More
Janssen synthesizes novel series of phosphodiesterase 10A inhibitors
Read More
New peptides with antibacterial activity presented by Universitat de Barcelona
Read More
Ingenium Pharmaceuticals designs new protein kinase inhibitors
Read More
Multifunctional fusion protein prevents HIV infection in vivo
Read More
Roche's new-generation glucose test strip receives FDA clearance
Read More
Ironwood's European partner Almirall submits linaclotide MAA
Read More
Health Canada approves single-pill combination drug for hypertension
Read More
JDRF and iCo Therapeutics partner to support phase II iCo-007 study
Read More
Dosing begins in proof-of-concept PEDigree trial
Read More
NanoCarrier and Kowa to enter worldwide agreement for NC-6300
Read More
Biodel announces phase I data on experimental insulins
Read More
FDA issues PDUFA target action date for Surfaxin NDA
Read More